Answer
Erdafitinib is embryotoxic and teratogenic based on its mechanism of action and animal reproduction studies, indicating potential harm to the fetus during pregnancy.
Sources for this answer
- Balversa 3mg film-coated tabletsJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.4 Special warnings and precautions for use · Version 3Document updated
Sources checked